What Is Hereditary Hemochromatosis?

Each drop of plasma goes on an extraordinary journey from the donor to the lab, and at CSL, we ensure its integrity every step of the way. From comprehensive donor screening and advanced collection to meticulous viral testing and a precise cold chain journey – our commitment to quality is unwavering. @[Wlenyeno Elliott-Browne], CSL’s Global Head of Plasma Quality, explains how this rigorous process is vital for delivering life-saving plasma-derived therapies to patients across the globe. Discover the dedication behind every unit of plasma in the video below. https://bit.ly/4x5wwol #CSL #PlasmaDonation #PlasmaDerivedTherapies

In honor of World Sickle Cell Day, learn more about two potential new treatment options for pan crises. More: https://lnkd.in/dYj9ismq #SCD #WorldSickleCellDay2026 #CSL

At CSL, your work goes beyond the ordinary — it saves lives. Through partnerships like the World Federation of Hemophilia Humanitarian Aid Program, we’re transforming care for inherited bleeding disorders and delivering hope where it’s needed most. If you want a career where your skills make a real difference, join us and help shape the future of medicine. 👉 Explore careers: csl.com/careers #CSL #CSLImpactReport #CSLCareers #PromisingFutures

At CSL, we believe improving patient outcomes starts with listening, learning and working together. During a recent field visit to Morocco with the World Federation of Hemophilia / Fédération mondiale de l'hémophilie (WFH) Humanitarian Aid Program, Dirk Hoheisel, SVP and Head CSL International, joined colleagues and partners on the ground to engage directly with patients, clinicians and local patient organisations. These conversations provided valuable insights into both the progress being made – and the work still ahead – to improve care for people living with bleeding disorders. The visit reinforced a clear perspective: humanitarian aid plays a critical role, but its greatest impact lies in what it enables. By combining access to treatment with education, advocacy and system strengthening, partnerships like the WFH program help countries move towards sustainable, nationally supported care. As one of the long-standing partners to WFH, we remain committed to contributing to this progress – supporting immediate patient needs while helping build the foundations for long-term solutions. We would also like to recognise Sujan Sivasubramaniyam, our Global Head of Patient Advocacy, whose leadership helps ensure patient perspectives remain at the centre of our approach. Together with our partners, we will continue working towards a future where access to care is equitable, sustainable and available to all who need it. #PatientAdvocacy #AccessToCare #Partnerships

Did you know that your body’s “invisible healer” plasma can be transformed into life-changing therapies for people living with rare and serious diseases? In case you missed it, @[Deborah Ebert Long MD], Head of Medical Affairs at CSL, explains the vital role of immunoglobulins, the proteins that defend us from threats, and details how CSL transforms these natural protectors into life-changing therapies to support people across the globe. #CSL #PlasmaDonation #PlasmaDerivedTherapies Watch the video below and learn more here: https://bit.ly/4x5wwol

Every passion for discovery starts somewhere. For Giorgia, it was on the coast of Croatia with her mother. Read Giorgia's story here: https://lnkd.in/dRN7U9-r #CSL #PeoplePoweringScience

Immunoglobulins, or antibodies, are Y-shaped proteins that help fight infections and diseases. Learn why they're critical to health in this one-minute video. #CSL #science #immunology

Congratulations to Karine Levesque on her re-election to the Board of Directors of LEEM, the organization representing France’s pharmaceutical industry and a key voice in advancing healthcare innovation and patient access. At CSL, patients remain at the heart of everything we do. Through collaboration across the French healthcare ecosystem, LEEM plays an important role in helping improve access to innovative therapies, supporting public health priorities, and strengthening the conditions needed to better serve patients in France. We are proud to contribute to these efforts and remain committed to helping ensure that patients across France can access the therapies they need, when they need them. We look forward to continuing to work alongside industry partners, healthcare stakeholders, and patient communities to support innovation and improve patient outcomes. Learn more about how CSL supports patients and public health: https://bit.ly/4aDjHrr #PatientsInFrance #PatientAccess #Healthcare #CSL

As a Principal Scientist in CSL’s cardiovascular and renal translational research team, Christopher builds and refines research models that give our potential therapeutic treatments their best shot at being successful.  Read Christopher’s story here: https://lnkd.in/dRN7U9-r #CSL #PeoplePoweringScience